Close

Cancer Genetics (CGIX), BARC Enter Partnership for Clinical Trials

September 20, 2016 7:31 AM EDT Send to a Friend
Cancer Genetics, Inc. (Nasdaq: CGIX) announced that it has entered into a partnership with the Bio Analytical Research Corporation (BARC) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login